Gilboa Therapeutics is a next-generation cancer immunotherapy company developing novel T cell therapies for solid cancers.

Biotechnology

Gilboa Therapeutics

Gilboa Therapeutics' headquarters in Rehovot, Israel

Itamar Levy

Jim Wooldridge

Ezra Cohen

Yaron Carmi

Michal Besser

Lawrence Fong

Keith Flaherty

The Research and Development Team at Gilboa Therapeutics focuses on advancing innovative T cell therapies for solid tumors. This multidisciplinary team, led by the R&D Director and supported by experts in immunology and scientific research, collaborates to conduct preclinical studies, optimize therapeutic strategies, and translate findings into effective treatments, driving the company's mission to improve patient outcomes in cancer care.

Research and Development Team

The Leadership Team at Gilboa Therapeutics is responsible for guiding the strategic vision and operational execution of the company. Comprising the CEO, COO, CTO, and key VPs, this team collaborates to advance innovative T cell therapies, drive research initiatives, ensure regulatory compliance, and foster partnerships that enhance the company's impact in the cancer immunotherapy landscape. Their collective expertise shapes the direction of the company and cultivates a culture of innovation and excellence.

Gilboa Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Offices

Gilboa Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Offices

Related companies